SCHEMBL9979418

SCHEMBL9979418

CCN(CC)[Si](c1ccccc1)(c1ccccc1)[Si](c1ccccc1)(c1ccccc1)N(CC)CC

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.36
TSHR P16473 3/20 0.35
ALDH1A1 P00352 2/20 0.35
GLA P06280 1/20 0.35
CHRM2 P08172 1/20 0.34
HTR1A P08908 1/20 0.34
ADRA2A P08913 1/20 0.34
CHRM1 P11229 1/20 0.34
DRD1 P21728 1/20 0.34
SLC6A2 P23975 1/20 0.34
SLC6A4 P31645 1/20 0.34
ADRA1A P35348 1/20 0.34
OPRM1 P35372 1/20 0.34
DRD3 P35462 1/20 0.34
SLC6A3 Q01959 1/20 0.34
KCNH2 Q12809 1/20 0.34
AOC3 Q16853 1/20 0.34
ESR1 P03372 1/20 0.33
ESR2 Q92731 1/20 0.33
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2102622 0.80 KCNH2 (0.39) TP53TSHRALDH1A1GLACHRM2
SCHEMBL2271289 0.80 TP53 (0.36) TP53TSHRALDH1A1GLACHRM2
SCHEMBL2100019 0.80 TP53 (0.36) TP53TSHRALDH1A1GLACHRM2
SCHEMBL2272577 0.78 ESR1 (0.37) TP53TSHRALDH1A1GLACHRM2
SCHEMBL2102653 0.78 ESR1 (0.37) TP53TSHRALDH1A1GLACHRM2
SCHEMBL10626373 0.78 ESR1 (0.37) TP53TSHRALDH1A1GLACHRM2
SCHEMBL9052501 0.76 ESR1 (0.35) TP53TSHRALDH1A1GLACHRM2
SCHEMBL2101348 0.76 TP53 (0.33) TP53TSHRALDH1A1GLACHRM2
SCHEMBL2101359 0.76 TSHR (0.33) TP53TSHRALDH1A1GLACHRM2
SCHEMBL2101242 0.76 ALDH1A1 (0.33) TP53TSHRALDH1A1GLACHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2580255-B1 POLYARYLACETYLENES CONTAINING SILOXANE, SILANE, AND CARBORANE MOIETIES US GOV SEC NAVY (US) 2016-09-07 EP disclosed
US-8440850-B2 Polyarylacetylenes containing siloxane, silane, and carborane moieties THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2013-05-14 US disclosed
EP-2580255-A2 POLYARYLACETYLENES CONTAINING SILOXANE, SILANE, AND CARBORANE MOIETIES The Government of the United States of America as represented by the Secretary of the Navy (US) 2013-04-17 EP disclosed
US-8269030-B2 Polyarylacetylenes containing siloxane, silane, and carborane moieties THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2012-09-18 US disclosed
US-20120190808-A1 POLYARYLACETYLENES CONTAINING SILOXANE, SILANE, AND CARBORANE MOIETIES THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2012-07-26 US disclosed
US-20120184699-A1 POLYARYLACETYLENES CONTAINING SILOXANE, SILANE, AND CARBORANE MOIETIES The Government of the United State of America, as represented by the Secretary of the Navy (US) 2012-07-19 US disclosed
US-8217194-B2 Polyarylacetylenes containing siloxane, silane, and carborane moieties THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2012-07-10 US disclosed
WO-2011156678-A2 POLYARYLACETYLENES CONTAINING SILOXANE, SILANE, AND CARBORANE MOIETIES THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2011-12-15 WO disclosed
US-20110306744-A1 POLYARYLACETYLENES CONTAINING SILOXANE, SILANE, AND CARBORANE MOIETIES THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2011-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110306744-A1 POLYARYLACETYLENES CONTAINING SILOXANE, SILANE, AND CARBORANE MOIETIES SIRT2, SUMO2, MCM2 TP53 1398/4885TSHR 4621/4885ALDH1A1 3215/4885
US-20120190808-A1 POLYARYLACETYLENES CONTAINING SILOXANE, SILANE, AND CARBORANE MOIETIES SIRT2, SUMO2, MCM2 TP53 1506/4885TSHR 4394/4885ALDH1A1 3588/4885
US-20120184699-A1 POLYARYLACETYLENES CONTAINING SILOXANE, SILANE, AND CARBORANE MOIETIES SIRT2, SUMO2, MCM2 TP53 1305/4885TSHR 4632/4885ALDH1A1 3126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.